Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105,977 | 81,565 | 72,406 | 101,252 | 130,055 |
| Marketable Securities | 5,991 | 14,918 | N/A | 15,968 | 29,813 |
| Receivables | 77,385 | 46,476 | N/A | N/A | N/A |
| Inventories | 4,333 | 2,312 | 1,659 | N/A | N/A |
| Other current assets | 5,196 | 5,638 | 2,462 | 3,318 | 2,643 |
| TOTAL | $205,630 | $159,158 | $84,433 | $130,314 | $172,781 |
| Non-Current Assets | |||||
| PPE Net | 5,646 | 6,129 | 6,660 | 6,786 | 11,170 |
| Intangibles | 3,563 | 3,563 | 3,563 | 3,563 | 3,563 |
| Other Non-Current Assets | 25,617 | 17,265 | 4,811 | 799 | 799 |
| TOTAL | $34,826 | $26,957 | $15,034 | $11,148 | $15,532 |
| Total Assets | $240,456 | $186,115 | $99,467 | $141,462 | $188,313 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,273 | 11,173 | 15,294 | 7,637 | 13,303 |
| Accrued Expenses | 39,755 | 28,094 | 17,548 | 16,498 | 8,510 |
| Other current liabilities | 2,198 | 2,140 | 419 | 402 | 385 |
| TOTAL | $61,226 | $41,407 | $33,261 | $24,537 | $22,198 |
| Non-Current Liabilities | |||||
| Long Term Debt | 73,286 | 73,124 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 109,929 | 110,099 | 104,797 | 104,549 | 104,331 |
| TOTAL | $183,215 | $183,223 | $104,797 | $104,531 | $104,284 |
| Total Liabilities | $244,441 | $224,630 | $138,058 | $129,068 | $126,482 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,764 | 69,370 | 69,260 | 68,025 | 67,821 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -981,268 | -1,004,835 | -984,831 | -922,235 | -863,427 |
| Other shareholders' equity | -511 | -418 | -282 | -420 | -1,878 |
| TOTAL | $-3,985 | $-38,515 | $-38,591 | $12,394 | $61,831 |
| Total Liabilities And Equity | $240,456 | $186,115 | $99,467 | $141,462 | $188,313 |